Brief: Xintela: Targinta Collaborates With MSK For Antibody Development
07/10/2025 10:45
Oct 7 (Reuters) - Xintela AB XINT.ST: TARGINTA COLLABORATES WITH MSK FOR ANTIBODY DEVELOPMENT Source text: ID:nMFN8G23g5 Further company coverage: XINT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Xintela AB
See all newsBrief: Xintela To Raise SEK 30 Mln Via Convertible Loan From Flerie Invest
Advisory: Alerts on Xintela's phase I/IIa XSTEM results withdrawn
Brief: Xintela Q1 2026 Loss Before Tax SEK 11.8 Mln
Brief: Xintela Study Finds XSTEM Treatment Safe, Well Tolerated
Brief: Xintela Gets U.S. Patent For Xstem Treatment Of Difficult-To-Heal Wounds, Skin Defects